Monogram

Monogram Biosciences, a subsidiary of LabCorp, is a biotechnology company specializing in molecular diagnostic testing for infectious diseases and oncology. The company is a leader in the development of phenotypic and genotypic assays, such as PhenoSense and Trofile, which are used to guide treatment decisions for HIV and Hepatitis C. Monogram's Trofile assay is the only clinically validated test for determining CCR5 coreceptor usage, a requirement for prescribing certain HIV entry inhibitors like maraviroc. In oncology, the company utilizes its proprietary VeraTag technology to provide precise measurements of protein expression and protein-protein complexes, aiding in the development of targeted therapies. Monogram serves as a key partner for pharmaceutical companies, providing specialized testing services for clinical trials and companion diagnostic development.